LIFE: Notification of Extraordinary General Meeting

Bergen, Norway 16.09.21

Today the Board of Directors (the "Board") of Lifecare AS (the "Company" or
"Lifecare") has passed a resolution to convene an Extraordinary General Meeting
("EGM") on 30 September 2021 to approve a revocation of a board authorization
for a share capital increase of up to NOK 3.238.093 of the Company's share
capital passed by the Company's EGM on 30 July 2020. The resolution is part of
the process towards the planned capital increase previously announced.  

Notice of the EGM is enclosed to this announcement. 

To save the environment and reduce costs incurred sending the notification by
post to the shareholders, please see attached a manual (in Norwegian) on how to
receive notices and information electronically instead of by post.

This is Lifecare
Lifecare is a Bergen-based technology company developing a miniaturized
implantable long-term sensor for correct and continuous monitoring of blood
sugar in people with diabetes. The company's patented technology also has the
potential for use in various biomarkers. Lifecare AS is listed on Euronext
Growth Oslo (LIFE).

Further information
Joacim Holter, CEO, Lifecare AS,  joacim.holter@lifecare.no, +47 40 05 90 40

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act. This stock exchange announcement was
published by Kine Hereid, Investor Relations at Lifecare AS, on 16.09.2021 at
16:30 CET.